Age-Related Macular Degeneration Market: Demand Forecast and Future Analysis (2034)
Age-Related Macular Degeneration Market Overview The age-related macular degeneration (AMD) market is a critical segment of ophthalmology, focusing on the diagnosis and treatment of AMD, a chronic eye disease affecting the macula and leading to vision loss. AMD primarily affects individuals over the age of 50 and is one of the leading causes of blindness among the elderly globally. The market’s growth is closely tied to the rising geriatric population , increasing prevalence of lifestyle-related risk factors such as hypertension and diabetes, and advancements in therapeutic interventions. Recent innovations, including anti-VEGF therapies, photodynamic therapy, and gene therapy, have significantly improved treatment outcomes, boosting market demand. Market Size and Share The age-related macular degeneration market was valued at USD 10.46 Billion in 2024 . The market is expected to expand at a CAGR of 9.70% during the forecast period of 2025-2034, reaching USD 26.40 Billion by 20...